Molina Healthcare (MOH) Stock Forecast & Price Target

$315.08 -9.73 (-3.00%)

Closing price 03:58 PM Eastern

Extended Trading

$312.64 -2.44 (-0.77%)

As of 04:06 PM Eastern

Molina Healthcare - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 14 Analyst Ratings

Sell
1

Hold
6

Buy
7

Based on 14 Wall Street analysts who have issued ratings for Molina Healthcare in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 1 has given a sell rating, 6 have given a hold rating, 6 have given a buy rating, and 1 has given a strong buy rating for MOH.

Consensus Price Target

$355.69
12.89% Upside

According to the 14 analysts' twelve-month price targets for Molina Healthcare, the average price target is $355.69. The highest price target for MOH is $439.00, while the lowest price target for MOH is $297.00. The average price target represents a forecasted upside of 12.89% from the current price of $315.08.

Get the Latest News and Ratings for MOH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Molina Healthcare and its competitors.

MOH Analyst Ratings Over Time

Type	Current Forecast 3/12/24 to 3/12/25	1 Month Ago 2/11/24 to 2/10/25	3 Months Ago 12/13/23 to 12/12/24	1 Year Ago 3/13/23 to 3/12/24
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	4 Buy rating(s)	5 Buy rating(s)	4 Buy rating(s)
Hold	6 Hold rating(s)	7 Hold rating(s)	6 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$355.69	$355.67	$367.17	$385.91
Forecasted Upside	12.89% Upside	24.27% Upside	23.60% Upside	-4.13% Downside
Consensus Rating	Moderate Buy	Hold	Hold	Moderate Buy

Remove Ads

MOH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MOH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Molina Healthcare Stock vs. The Competition

Type	Molina Healthcare	Medical Companies	S&P 500
Consensus Rating Score	2.50	2.82	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	12.25% Upside	25,443.63% Upside	20.11% Upside
News Sentiment Rating	Positive News See Recent MOH News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/5/2025	Wells Fargo & Company 3 of 5 stars	Stephen Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$295.00 ➝ $372.00	+21.56%
3/3/2025	Mizuho 2 of 5 stars	Ann Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$382.00 ➝ $376.00	+24.60%
2/19/2025	Truist Financial 2 of 5 stars	David Macdonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$370.00 ➝ $340.00	+23.55%
2/7/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$372.00 ➝ $339.00	+19.40%
2/7/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$374.00 ➝ $325.00	+13.15%
2/6/2025	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raj Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight	$345.00 ➝ $345.00	+19.20%
12/17/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Neutral	$378.00 ➝ $350.00	+18.42%
10/24/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$406.00 ➝ $406.00	+22.41%
10/24/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$405.00 ➝ $331.00	+20.48%
7/29/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$354.00 ➝ $353.00	+6.02%
Get the Latest News and Ratings for MOH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Molina Healthcare and its competitors with MarketBeat's FREE daily newsletter.
7/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$354.00 ➝ $297.00	+2.86%
7/24/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$412.00 ➝ $351.00	+21.57%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
3/28/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underperform	$439.00	+4.90%
7/14/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$365.00	+21.87%
4/28/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$347.00 ➝ $350.00	+17.88%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:07 PM ET.

Should I Buy Molina Healthcare Stock? MOH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, March 3, 2025. Please send any questions or comments about these Molina Healthcare pros and cons to contact@marketbeat.com.

Molina Healthcare
Bull Case

Here are some ways that investors could benefit from investing in Molina Healthcare, Inc.:

The current stock price is approximately $293.26, which is below its 200-day moving average of $312.75, indicating potential for price appreciation.
Molina Healthcare, Inc. has a strong return on equity of 28.13%, suggesting effective management and profitability, which can attract investors looking for solid performance.
The company has a market capitalization of $16.73 billion, indicating it is a significant player in the healthcare sector, which can provide stability and growth potential.
Institutional investors own 98.50% of the company's stock, reflecting strong confidence from large financial entities in Molina Healthcare, Inc.'s future prospects.
The firm has a relatively low P/E ratio of 14.76 compared to industry averages, suggesting that the stock may be undervalued and could offer a good entry point for investors.

Molina Healthcare
Bear Case

Investors should be bearish about investing in Molina Healthcare, Inc. for these reasons:

The company reported earnings per share of $5.05, which missed the consensus estimate of $5.74, indicating potential challenges in meeting market expectations.
Molina Healthcare, Inc. has a net margin of only 2.90%, which may suggest limited profitability and could be a concern for investors focused on high-margin companies.
Recent price target reductions by analysts, such as Truist Financial lowering their target from $370.00 to $340.00, may indicate a bearish outlook on the stock's near-term performance.
The stock has a beta of 0.54, indicating lower volatility compared to the market, which may not appeal to investors seeking high-risk, high-reward opportunities.
Despite a strong institutional ownership, the presence of a sell rating from one analyst could signal caution for potential investors considering the stock.

MOH Forecast - Frequently Asked Questions

: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Molina Healthcare is $355.69, with a high forecast of $439.00 and a low forecast of $297.00.
: 14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Molina Healthcare in the last twelve months. There is currently 1 sell rating, 6 hold ratings, 6 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MOH shares.
: According to analysts, Molina Healthcare's stock has a predicted upside of 12.89% based on their 12-month stock forecasts.
: Over the previous 90 days, Molina Healthcare's stock had 1 upgrade by analysts.
: Molina Healthcare has been rated by research analysts at Barclays, JPMorgan Chase & Co., Mizuho, Stephens, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Molina Healthcare less than other "medical" companies. The consensus rating score for Molina Healthcare is 2.50 while the average consensus rating score for "medical" companies is 2.82. Learn more on how MOH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:MOH) was last updated on 3/12/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Molina Healthcare (MOH) Stock Forecast & Price Target